| ALP | Alkaline phosphatase |
| BMD | Bone mineral density |
| CAC | Coronary artery calcification |
| Ca × P | Calcium–phosphate product |
| CENTRAL | Cochrane Central Register of Controlled Trials |
| CI | Confidence interval |
| cIMT | Carotid intima–media thickness |
| CKD | Chronic kidney disease |
| CKD–MBD | Chronic kidney disease–mineral and bone disorder |
| CTX | C-terminal telopeptide of type I collagen |
| dCa | Dialysate calcium |
| DXA | Dual-energy X-ray absorptiometry |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| HD | Hemodialysis |
| HDF | Hemodiafiltration |
| MAP | Mean arterial pressure |
| MD | Mean difference |
| P1NP | Procollagen type I N-terminal propeptide |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROSPERO | International Prospective Register of Systematic Reviews |
| PTH | Parathyroid hormone |
| QCT | Quantitative computed tomography |
| QT | QT interval |
| QTc | Corrected QT interval |
| RCT | Randomized controlled trial |
| RoB 2 | Cochrane Risk of Bias 2 |
| SBP | Systolic blood pressure |
| SMD | Standardized mean difference |